Basic Information

Gene symbol MAGEA4 Synonyms CT1.4, MAGE-41, MAGE-X2, MAGE4, MAGE4A, MAGE4B Type of gene protein-coding
Description MAGE family member A4

GTO ID GTC0570
Trial ID UMIN000002395
Disease Esophageal Cancer
Altered gene MAGE-A4
Therapeutic/Target gene Target gene
TherapyTCR-T cell
Treatment MAGE-A4 TCR-T cells
HLAHLA-A*24:02
PhasePhase1
Recruitment statusCompleted
TitleAdoptive transfer of lymphocytes transduced with MAGE-A4-specific TCR gene
Year2009
CountryJapan
Company sponsorMie University Hospital
Vector information
Vectorretrovirus
Transgene/Inserted geneDNA encoding MAGE-A4143-151/HLA-A*24:02-specific TCR-α and -β chains
Vector production methodLymphocytes were collected from each patient by processing 5 L of peripheral blood by apheresis. In the cell-processing facility, the lymphocytes were cultured with IL2, anti-CD3 antibody, and RetroNectin (Takara Bio Inc.) under institutional GMP control. Proliferating lymphocytes were infected with the retroviral vector, MS-bPa.After 7-10 days in culture, the lymphocytes were harvested and then frozen until use.

Clinical Result

Cohort 1
Administration route infusion
Dosage 0.2~5E9 cells
Donor type autologous
Pts 10
Age Adult, Older_Adult
Lymph depletion No
Outcome 7/10(PD)
Adverse reactions 4/10(Skin redness and induration)
References PMID: 25855804

Relationship Graph

Overview of Knowledge Graph